← Core Scientific, Inc./tx
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Depreciation and amortization | $9.4m | $33.4m | $225.3m | $96.0m | $113.2m | $68.9m | |
| Amortization of debt discount | $1.3m | $1.4m | $7.1m | $752k | $3.8m | $6.0m | |
| Impairment of property, plant and equipment | $19.9m | $0 | $0 | $0 | $122.9m | $11.4m | |
| Impairment of digital assets | $4k | $37.2m | $231.3m | $4.4m | $0 | $0 | |
| Loss on disposal of property, plant and equipment | $2k | $118k | $28.0m | $2.0m | $4.2m | $9.7m | |
| Loss (gain) on debt extinguishment | $1.3m | $8.0m | $287k | ($20.1m) | $487k | $1.9m | |
| Non-cash PIK interest expense | $0 | $7.3m | $31.4m | $0 | $3.7m | $0 | |
| Purchase of equity investments | — | — | — | $0 | $0 | ($5.0m) | |
| Net loss | ($12.2m) | ($32.5m) | ($2.1b) | ($246.5m) | ($1.3b) | ($288.6m) | |
| Change in right-of-use assets | — | $0 | $834k | $442k | $6.9m | $11.3m | |
| Stock-based compensation | $3.0m | $38.9m | $182.9m | $58.9m | $51.9m | $98.2m | |
| Digital asset self-mining | — | — | ($397.8m) | ($407.1m) | ($425.3m) | ($229.7m) | |
| Proceeds from sale of digital assets generated by self-mining and shared hosting revenues | — | — | $444.4m | $404.7m | $402.5m | $0 | |
| Decrease in fair value of digital assets | — | — | $0 | $0 | $1.1m | $31.6m | |
| Gain from sale of digital assets | — | — | ($44.3m) | ($3.9m) | $0 | $0 | |
| Change in fair value of energy derivatives | — | — | $0 | $0 | ($2.3m) | $0 | |
| Increase in fair value of warrant liabilities | $0 | $26.3m | ($37.9m) | $0 | $2.9b | $40.9m | |
| Decrease in fair value of contingent value rights | — | — | $0 | $0 | ($82.1m) | ($906k) | |
| Loss on issuance of notes payable through settlements | — | $0 | $0 | $8.5m | $0 | $0 | |
| Non-cash reorganization items | — | — | ($199.7m) | $0 | ($143.8m) | $0 | |
| Accounts receivable, net | ($1.3m) | ($7.4m) | ($7.9m) | ($767k) | $659k | $0 | |
| Accounts receivable from related parties | ($243k) | $16k | $277k | $23k | $0 | $0 | |
| Deposits for equipment for sales to customers | ($54.7m) | ($244.4m) | $50.2m | ($2.4m) | $0 | $0 | |
| Customer funding receivable and other current assets | — | ($34.1m) | $51.8m | ($18.4m) | ($20.4m) | $16.2m | |
| Accounts payable | ($1.8m) | $263k | $26.7m | $118.6m | ($12.3m) | $10.8m | |
| Accrued expenses | $1.6m | $3.2m | $17.2m | $130.4m | $1.9m | ($17.4m) | |
| Deferred revenue from services | — | — | $16.5m | ($47.8m) | $8.3m | $537.7m | |
| Other noncurrent assets and liabilities, net | $1.6m | ($6.2m) | ($3.8m) | ($13.0m) | ($5.8m) | ($22.8m) | |
| Proceeds from sales of property and equipment | $19.9m | $0 | $0 | $14.0m | $0 | $3.5m | |
| Proceeds from sale of Cedarvale | — | $0 | $0 | $14.0m | $0 | $0 | |
| Investments in intangible assets | — | — | — | ($833k) | ($231k) | ($10.2m) | |
| Principal repayments of finance leases | ($1.8m) | ($7.8m) | ($30.3m) | ($3.7m) | ($6.0m) | ($1.7m) | |
| Proceeds for the issuance of senior convertible notes, net | — | — | $0 | $0 | $1.1b | $0 | |
| Issuance costs for senior convertible notes | — | — | $0 | $0 | ($3.8m) | $0 | |
| Proceeds from draw from exit facility | — | — | $0 | $0 | $20.0m | $0 | |
| Restricted stock tax holding obligations | — | $0 | ($31.6m) | $0 | ($3.4m) | $0 | |
| Proceeds from exercise of warrants | — | — | — | $0 | $4.9m | $6.9m | |
| Proceeds from exercise of stock options | — | — | $25.0m | $0 | $9k | $0 | |
| Net cash provided by operating activities | ($23.8m) | ($1.9m) | $205.2m | $65.1m | $42.9m | $278.2m | |
| Purchases of property, plant and equipment | $0 | $0 | ($384.0m) | ($16.2m) | ($95.0m) | ($729.0m) | |
| Net cash used in investing activities | ($15.1m) | ($345.0m) | ($590.8m) | ($3.0m) | ($95.2m) | ($740.8m) | |
| Principal payments on debt | ($5.3m) | ($49.3m) | ($113.3m) | ($41.0m) | ($304.8m) | ($8.6m) | |
| Debt extinguishment payments | — | — | — | $0 | $0 | ($27.5m) | |
| Proceeds from issuance of new common stock | — | — | $0 | $0 | $55.0m | $0 | |
| Net cash (used in) provided by financing activities | $40.7m | $347.8m | $306.2m | ($44.6m) | $819.6m | ($63.1m) | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | $1.8m | $971k | ($79.4m) | $17.5m | $767.3m | ($525.6m) | |
| Cash, cash equivalents and restricted cash—beginning of period | $8.7m | $131.7m | $52.2m | $69.7m | $837.0m | $311.4m | |
| Cash and cash equivalents | — | $971k | $15.9m | $50.4m | $836.2m | $311.4m | |
| Restricted cash | — | $13.8m | $36.4m | $19.3m | $783k | $0 | |
| Taxes paid related to net share settlement of equity awards | — | — | — | $0 | $0 | ($32.2m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.